3
Announcements
Trials
Browse
Landscape
Status
Completed
26
Recruiting
6
Unknown
5
Terminated
2
Not yet recruiting
2
Withdrawn
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Fatigue
5
Breast Neoplasms
5
Sleep Wake Disorders
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Leukemia, Myeloid, Acute
2
Hodgkin Disease
2
Depression
2
Congenital Abnormalities
2
Carcinoma, Ovarian Epithelial
2
Vomiting
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Initiation and Maintenance Disorders
1
Sezary Syndrome
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Salivary Gland Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Nausea
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
Cisplatin
9
pembrolizumab
7
Radiosurgery
6
Gemcitabine
6
Paclitaxel
5
Dexamethasone
5
Taxes
4
Carboplatin
4
trametinib
3
ibrutinib
3
Surveys and Questionnaires
3
Standard of Care
3
Radiotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Fluorouracil
3
Erlotinib Hydrochloride
3
Blood Specimen Collection
3
Ascorbic Acid
3
venetoclax
2
veliparib
2
tocilizumab
2
pazopanib
2
obinutuzumab
2
naquotinib
2
lenvatinib
2
fludarabine
2
enzalutamide
2
Vemurafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Neoplasms
×
Therapeutics
×
Clear all
NCT02896049
2021-07-27
Celsius TCS Hyperthermia System PMCF Trial
Celsius42 GmbH
Withdrawn